Filed: 11/14/2024ACC: 0000919574-24-006599
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $24.16M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$24.16M
Total AUM (reported)
6.61M
Total Shares
Allocation by class
COM$15.27M63.2%
COM NEW$6.59M27.3%
TR UNIT$1.64M6.8%
CL B NEW$529.6K2.2%
SPONSORED ADS$130.9K0.5%
Portfolio Concentration
Top 3$22.61M93.6%
4–10$1.49M6.2%
11–25$61.3K0.3%
Top 3 weight
93.6%
Top 10 weight
99.7%
Voting Authority Distribution
Total shares with voting rights: 6.61M
Sole
Full voting authority
6.61M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
XERIS BIOPHARMA HOLDINGS INC
SOLEShares5.11M
TypeSH
Market value$14.57M
60.31%
Sole
5.11M
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.32M
TypeSH
Market value$6.40M
26.47%
Sole
1.32M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares2.87K
TypeSH
Market value$1.64M
6.81%
Sole
2.87K
Shared
0.00
None
0.00
BERKSHIRE HATHAWAY INC DEL
SOLEShares1.15K
TypeSH
Market value$529.6K
2.19%
Sole
1.15K
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares10.94K
TypeSH
Market value$278.7K
1.15%
Sole
10.94K
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares34.07K
TypeSH
Market value$193.9K
0.80%
Sole
34.07K
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares17.85K
TypeSH
Market value$161.4K
0.67%
Sole
17.85K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares11.37K
TypeSH
Market value$130.9K
0.54%
Sole
11.37K
Shared
0.00
None
0.00
KYVERNA THERAPEUTICS INC
SOLEShares22.98K
TypeSH
Market value$112.4K
0.47%
Sole
22.98K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares43.47K
TypeSH
Market value$80.0K
0.33%
Sole
43.47K
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
SOLEShares18.40K
TypeSH
Market value$36.1K
0.15%
Sole
18.40K
Shared
0.00
None
0.00
ADICET BIO INC
SOLEShares17.49K
TypeSH
Market value$25.2K
0.10%
Sole
17.49K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 5.11M | SH | $14.57M 60.31% | 5.11M | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.32M | SH | $6.40M 26.47% | 1.32M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 2.87K | SH | $1.64M 6.81% | 2.87K | 0.00 | 0.00 |
BERKSHIRE HATHAWAY INC DELSOLE | CL B NEW | 1.15K | SH | $529.6K 2.19% | 1.15K | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 10.94K | SH | $278.7K 1.15% | 10.94K | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 34.07K | SH | $193.9K 0.80% | 34.07K | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 17.85K | SH | $161.4K 0.67% | 17.85K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 11.37K | SH | $130.9K 0.54% | 11.37K | 0.00 | 0.00 |
KYVERNA THERAPEUTICS INCSOLE | COM | 22.98K | SH | $112.4K 0.47% | 22.98K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 43.47K | SH | $80.0K 0.33% | 43.47K | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCSOLE | COM | 18.40K | SH | $36.1K 0.15% | 18.40K | 0.00 | 0.00 |
ADICET BIO INCSOLE | COM | 17.49K | SH | $25.2K 0.10% | 17.49K | 0.00 | 0.00 |